Envoy Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	0.3	0.32	0.24	0.31
Revenue Growth (YoY)	38.79%	33.33%	-23.55%	-
Cost of Revenue	0.91	0.79	0.5	0.77
Gross Profit	-0.61	-0.47	-0.26	-0.46
Selling, General & Admin	9.64	8.94	3.47	2.47
Research & Development	9.25	8.96	4.98	3.94
Operating Expenses	18.89	17.9	8.45	6.41
Operating Income	-19.5	-18.37	-8.71	-6.87
Interest Expense / Income	0.04	0	0	0
Other Expense / Income	3.5	11.54	7.22	1.8
Pretax Income	-23.04	-29.91	-15.92	-8.68
Net Income	-23.04	-29.91	-15.92	-8.68
Preferred Dividends	0.5	0	0	2
Net Income Common	-23.54	-29.91	-15.92	-10.68
Shares Outstanding (Basic)	20	13	10	139
Shares Outstanding (Diluted)	20	13	10	139
Shares Change	93.63%	24.00%	-92.73%	-
EPS (Basic)	-0.21	-2.38	-1.57	-0.08
EPS (Diluted)	-0.21	-2.38	-1.57	-0.08
Free Cash Flow	-21.58	-17.81	-9.02	-7.06
Free Cash Flow Per Share	-1.10	-1.42	-0.89	-0.05
Gross Margin	-206.06%	-149.68%	-110.13%	-148.06%
Operating Margin	-6564.98%	-5813.61%	-3673.42%	-2216.45%
Profit Margin	-7924.92%	-9464.56%	-6718.57%	-3443.55%
Free Cash Flow Margin	-7266.81%	-5635.13%	-3807.17%	-2277.74%
EBITDA	-22.83	-29.78	-15.85	-8.6
EBITDA Margin	-7688.22%	-9422.47%	-6686.92%	-2775.48%
Depreciation & Amortization	0.17	0.13	0.08	0.07
EBIT	-23	-29.91	-15.92	-8.68
EBIT Margin	-7744.44%	-9464.56%	-6718.57%	-2798.39%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).